Bevacizumab for the Treatment of High-Grade Meningiomas: Is There New Evidence? [Letter]

da Silva VTG, Gebrin T, Paiva WS

Neuropsychiatric Disease and Treatment 2022, 18:2453-2454

Published Date: 27 October 2022